LFG
TMO icon

Larson Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Larson Financial Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.98M Sell
9,924
-1,357
-12% -$651K 0.13% 129
2026
Q1 		$5.54M Buy
11,281
+1,316
+13% +$714K 0.18% 104
2025
Q4 		$5.77M Sell
9,965
-440
-4% -$249K 0.19% 99
2025
Q3 		$5.05M Buy
10,405
+860
+9% +$400K 0.18% 114
2025
Q2 		$3.87M Buy
9,545
+2,288
+32% +$957K 0.15% 126
2025
Q1 		$3.61M Buy
7,257
+1,845
+34% +$999K 0.17% 113
2024
Q4 		$2.82M Buy
5,412
+523
+11% +$288K 0.15% 129
2024
Q3 		$3.02M Buy
4,889
+328
+7% +$194K 0.17% 110
2024
Q2 		$2.52M Sell
4,561
-498
-10% -$285K 0.17% 104
2024
Q1 		$2.94M Buy
5,059
+34
+0.7% +$19.1K 0.23% 84
2023
Q4 		$2.67M Buy
5,025
+875
+21% +$424K 0.23% 79
2023
Q3 		$2.1M Sell
4,150
-122
-3% -$65K 0.21% 93
2023
Q2 		$2.23M Sell
4,272
-126
-3% -$68K 0.22% 84
2023
Q1 		$2.53M Buy
4,398
+121
+3% +$68.2K 0.28% 70
2022
Q4 		$2.36M Sell
4,277
-274
-6% -$145K 0.28% 73
2022
Q3 		$2.31M Buy
4,551
+4,361
+2,295% +$2.44M 0.33% 51
2022
Q2 		$103K Buy
190
+128
+206% +$70.5K 0.02% 254
2022
Q1 		$37K Sell
62
-54
-47% -$31K 0.01% 427
2021
Q4 		$77K Buy
116
+71
+158% +$44.3K 0.01% 316
2021
Q3 		$26K Hold
45
– – 0.01% 419
2021
Q2 		$23K Hold
45
– – 0.01% 414
2021
Q1 		$21K Sell
45
-27
-38% -$12.9K 0.01% 408
2020
Q4 		$34K Buy
72
+20
+38% +$9.38K 0.01% 277
2020
Q3 		$23K Sell
52
-2
-4% -$826 0.01% 297
2020
Q2 		$20K Buy
54
+1
+2% +$335 0.01% 287
2020
Q1 		$15K Buy
53
+42
+382% +$13.2K 0.01% 248
2019
Q4 		$4K Buy
+11
New +$3.33K ﹤0.01% 399

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Larson Financial Group's TMO Position: Q2 2026 in Review

Larson Financial Group reduced its Thermo Fisher Scientific (TMO) stake by 12% in Q2 2026, selling an estimated $651K and leaving 9,924 shares worth $4.98M. The position accounts for 0.13% of the portfolio, ranked #129.

Larson Financial Group first reported a position in TMO in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.77M in Q4 2025. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Larson Financial Group held 9,924 shares of Thermo Fisher Scientific worth $4.98M as of Q2 2026.
  • Larson Financial Group sold 1,357 Thermo Fisher Scientific shares in Q2 2026, an estimated $651K.
  • Thermo Fisher Scientific made up 0.13% of Larson Financial Group's portfolio in Q2 2026, its #129 holding.
  • Larson Financial Group first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 27 quarters since.
  • Larson Financial Group's Thermo Fisher Scientific position peaked at $5.77M in Q4 2025.
  • 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.